149 related articles for article (PubMed ID: 10435734)
1. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Iacopino P; Pucci G; Arcese W; Bosi A; Falda M; Locatelli F; Marenco P; Miniero R; Morabito F; Rossetti F; Sica S; Uderzo C; Bacigalupo A
Bone Marrow Transplant; 1999 Jul; 24(1):47-51. PubMed ID: 10435734
[TBL] [Abstract][Full Text] [Related]
2. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
[TBL] [Abstract][Full Text] [Related]
3. Early deaths in children after BMT. Bone Marrow Transplantation Group of the Italian Association for Pediatric Hematology and Oncology (AIEOP) and Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Garaventa A; Porta F; Rondelli R; Dini G; Meloni G; Bonetti F; Uderzo C; De Manzini A; Miniero R; Brutti F
Bone Marrow Transplant; 1992 Nov; 10(5):419-23. PubMed ID: 1464003
[TBL] [Abstract][Full Text] [Related]
4. Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation.
Akiyama H; Yoshinaga H; Endou M; Tanikawa S; Sakamaki H; Tanoue K; Onozawa Y
Bone Marrow Transplant; 1997 Aug; 20(3):261-3. PubMed ID: 9257898
[TBL] [Abstract][Full Text] [Related]
5. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura: a rare late complication of allogeneic bone marrow transplantation.
Pucci G; Martino M; Morabito F; Iacopino P; Arcese W; Iori AP; Lombardo VT; L'Abbate A; Santostefano M; Nobile F
Haematologica; 1994; 79(4):371-3. PubMed ID: 7806094
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy following bone marrow transplantation.
Pettitt AR; Clark RE
Bone Marrow Transplant; 1994 Oct; 14(4):495-504. PubMed ID: 7858524
[TBL] [Abstract][Full Text] [Related]
9. Haemolytic uraemic syndrome following bone marrow transplantation. Case report and review of the literature.
Verburgh CA; Vermeij CG; Zijlmans JM; van Veen S; van Es LA
Nephrol Dial Transplant; 1996 Jul; 11(7):1332-7. PubMed ID: 8672033
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
[TBL] [Abstract][Full Text] [Related]
11. Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?
Llamas P; Romero R; Cabrera R; Sanjuán I; Forés R; Fernández MN
Bone Marrow Transplant; 1997 Aug; 20(4):305-6. PubMed ID: 9285545
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood acute lymphoblastic leukemia in first remission with allogeneic bone marrow transplantation or with intensive chemotherapy: a cooperative Italian study. The AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo), Italy.
Uderzo C; Valsecchi MG; Balduzzi A; Rovelli A; Dini G; Miniero R; Locatelli F; Rondelli R; Arcese W; Andolina M; Messina C; Polchi P; Biagi E; Arrigo C; Silvestri D; Masera G; Bacigalupo A
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():25-7. PubMed ID: 8932793
[No Abstract] [Full Text] [Related]
13. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy.
Zeigler ZR; Shadduck RK; Nath R; Andrews DF
Bone Marrow Transplant; 1996 Jan; 17(1):81-6. PubMed ID: 8673060
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
[TBL] [Abstract][Full Text] [Related]
15. Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo).
Buggia I; Zecca M; Alessandrino EP; Locatelli F; Rosti G; Bosi A; Pession A; Rotoli B; Majolino I; Dallorso A; Regazzi MB
Anticancer Res; 1996; 16(4A):2083-8. PubMed ID: 8712747
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation.
Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
Clin Transplant; 2005 Jun; 19(3):418-22. PubMed ID: 15877808
[TBL] [Abstract][Full Text] [Related]
17. Association of Helicobacter pylori with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome after bone marrow transplantation.
Takatsuka H; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H; Kakishita E
Clin Transplant; 2004 Oct; 18(5):547-51. PubMed ID: 15344958
[TBL] [Abstract][Full Text] [Related]
18. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.
Kennedy GA; Bleakley S; Butler J; Mudie K; Kearey N; Durrant S
Transfusion; 2009 Sep; 49(9):1884-9. PubMed ID: 19453982
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
